Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (301-310 of 1,367) with videos related to

Pageof 137
Sort By:
Ejhaem|August 21, 2023
Familial immune-mediated aplastic anaemia in six different familiesTatsuya Imi, Hiroki Mizumaki, Kazuyoshi Hosomichi, et al.
Ejhaem|August 21, 2023
Selinexor: Targeting a novel pathway in multiple myelomaClifton C Mo, Andrew J Yee, Shonali Midha, et al.
Ejhaem|August 21, 2023
Results of a phase 1/2 study of cemdisiran in healthy subjects and patients with paroxysmal nocturnal hemoglobinuriaAnna Gaya, Talha Munir, Alvaro Urbano-Ispizua, et al.
Ejhaem|August 21, 2023
Evidence of clinical efficacy of a first generation CD19 CAR T cell in B cell malignanciesKyrillus S Shohdy, Manon Pillai, Ryan Guest, et al.
Ejhaem|November 29, 2023
Returning to employment following allogeneic hematopoietic stem cell transplant: A major problem among survivorsLuis Filgueira, Amir Steinberg, Rochelle Mendonca, et al.
Ejhaem|November 29, 2023
The real-world use and efficacy of pomalidomide for relapsed and refractory multiple myeloma in the era of CD38 antibodiesAgoston Gyula Szabo, Jonathan Thorsen, Katrine Fladeland Iversen, et al.
Ejhaem|November 29, 2023
Persistence of <i>UBTF</i> tandem duplications in remission in acute myeloid leukaemiaSean Harrop, Phillip C Nguyen, David Byrne, et al.
Ejhaem|November 29, 2023
Ultrafast 30-min infusion of a rituximab biosimilar (Truxima)Ernesto Pérez-Persona, Laida Cuevas Palomares, Ariane Unamunzaga Cilaurren, et al.
Ejhaem|November 29, 2023
The <i>JAK2</i> mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burdenLai Yee Orbell, Nouf Abutheraa, Andrew S Duncombe, et al.
Ejhaem|November 29, 2023
Overcoming barriers to drug development and enrollment in clinical trials for adolescents and young adults with lymphomaKeri Toner, Carl E Allen, Shweta Jain, et al.
Pageof 137

Showing results (301-310 of 1,367) with videos related to

Sort By:
Pageof 137
Ejhaem|August 21, 2023
Familial immune-mediated aplastic anaemia in six different familiesTatsuya Imi, Hiroki Mizumaki, Kazuyoshi Hosomichi, et al.
Ejhaem|August 21, 2023
Selinexor: Targeting a novel pathway in multiple myelomaClifton C Mo, Andrew J Yee, Shonali Midha, et al.
Ejhaem|August 21, 2023
Results of a phase 1/2 study of cemdisiran in healthy subjects and patients with paroxysmal nocturnal hemoglobinuriaAnna Gaya, Talha Munir, Alvaro Urbano-Ispizua, et al.
Ejhaem|August 21, 2023
Evidence of clinical efficacy of a first generation CD19 CAR T cell in B cell malignanciesKyrillus S Shohdy, Manon Pillai, Ryan Guest, et al.
Ejhaem|November 29, 2023
Returning to employment following allogeneic hematopoietic stem cell transplant: A major problem among survivorsLuis Filgueira, Amir Steinberg, Rochelle Mendonca, et al.
Ejhaem|November 29, 2023
The real-world use and efficacy of pomalidomide for relapsed and refractory multiple myeloma in the era of CD38 antibodiesAgoston Gyula Szabo, Jonathan Thorsen, Katrine Fladeland Iversen, et al.
Ejhaem|November 29, 2023
Persistence of <i>UBTF</i> tandem duplications in remission in acute myeloid leukaemiaSean Harrop, Phillip C Nguyen, David Byrne, et al.
Ejhaem|November 29, 2023
Ultrafast 30-min infusion of a rituximab biosimilar (Truxima)Ernesto Pérez-Persona, Laida Cuevas Palomares, Ariane Unamunzaga Cilaurren, et al.
Ejhaem|November 29, 2023
The <i>JAK2</i> mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burdenLai Yee Orbell, Nouf Abutheraa, Andrew S Duncombe, et al.
Ejhaem|November 29, 2023
Overcoming barriers to drug development and enrollment in clinical trials for adolescents and young adults with lymphomaKeri Toner, Carl E Allen, Shweta Jain, et al.
Pageof 137